Previous studies have shown that niclosamide can prevent adipocytes from undergoing epithelial−mesenchymal transition via the paracrine IL-6/Stat3 signaling pathway, thereby suppressing the occurrence and development of BRCA (58). Here, STAT3 is linked to invasive breast carcinoma.